NASDAQ:VERO Venus Concept (VERO) Stock Price, News & Analysis → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free VERO Stock Alerts $0.72 -0.04 (-5.26%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$0.72▼$0.7950-Day Range$0.61▼$1.8652-Week Range$0.60▼$4.70Volume10,084 shsAverage Volume27,119 shsMarket Capitalization$4.58 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Venus Concept alerts: Email Address Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About Venus Concept Stock (NASDAQ:VERO)Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.Read More VERO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VERO Stock News HeadlinesApril 24, 2024 | finance.yahoo.comVenus Concept Announces Loan Purchase and Completion of First Phase of RefinancingApril 15, 2024 | globenewswire.comVenus Concept to Release First Quarter of Fiscal Year 2024 Financial Results on May 15, 2024April 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.April 9, 2024 | finanznachrichten.deVenus Concept Inc.: Venus Concept Announces Israeli Regulatory Approval for Venus Bliss MAXApril 8, 2024 | markets.businessinsider.comVenus Concept Announces Approval For Venus Bliss MAX In Israel - Quick FactsApril 8, 2024 | globenewswire.comVenus Concept Announces Israeli Regulatory Approval for Venus Bliss MAXApril 3, 2024 | news.yahoo.comOn heels on Vero Beach, Sebastian growth, Fellsmere population to double in five years?April 3, 2024 | finance.yahoo.comVenus Concept Announces Australian Regulatory Approval for Venus Versa ProApril 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.April 3, 2024 | globenewswire.comVenus Concept Announces Australian Regulatory Approval for Venus Versa ProApril 2, 2024 | finanznachrichten.deVenus Concept Inc.: Venus Concept Announces Fourth Quarter and Fiscal Year 2023 Financial ResultsApril 1, 2024 | investorplace.comVERO Stock Earnings: Venus Concept Misses EPS, Misses Revenue for Q4 2023April 1, 2024 | globenewswire.comVenus Concept Announces Fourth Quarter and Fiscal Year 2023 Financial ResultsMarch 26, 2024 | finanznachrichten.deVenus Concept Inc.: Venus Concept Granted Continued Listing from Nasdaq Hearings Panel, Subject to Return to Compliance with Nasdaq Listing RulesMarch 25, 2024 | globenewswire.comVenus Concept Granted Continued Listing from Nasdaq Hearings Panel, Subject to Return to Compliance with Nasdaq Listing RulesMarch 13, 2024 | stockhouse.comVenus Concept Launches "NEXThetics" ProgramMarch 12, 2024 | globenewswire.comVenus Concept Launches “NEXThetics” ProgramFebruary 27, 2024 | globenewswire.comVenus Concept Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesFebruary 23, 2024 | globenewswire.comVenus Concept Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesFebruary 23, 2024 | msn.comNasdaq Surges 300 Points; NVIDIA Posts Strong ResultsFebruary 22, 2024 | finance.yahoo.comVenus Concept Announces CE Mark for Venus Versa Pro in EuropeFebruary 22, 2024 | globenewswire.comVenus Concept Announces CE Mark for Venus Versa Pro in EuropeFebruary 20, 2024 | finance.yahoo.comVenus Concept to Release Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024February 20, 2024 | globenewswire.comVenus Concept to Release Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024February 6, 2024 | finance.yahoo.comVenus Concept Inc. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 13thJanuary 24, 2024 | finance.yahoo.comVenus Concept Inc. Announces Review of Strategic AlternativesJanuary 21, 2024 | morningstar.comVenus Concept Inc VEROSee More Headlines Receive VERO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Venus Concept and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/01/2024Today4/25/2024Next Earnings (Confirmed)5/15/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:VERO CUSIPN/A CIK1409269 Webwww.venusconcept.com Phone(888) 907-0115FaxN/AEmployees304Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($6.85) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-37,250,000.00 Net Margins-48.79% Pretax Margin-48.62% Return on EquityN/A Return on Assets-36.21% Debt Debt-to-Equity RatioN/A Current Ratio2.13 Quick Ratio1.39 Sales & Book Value Annual Sales$76.35 million Price / Sales0.06 Cash FlowN/A Price / Cash FlowN/A Book Value($2.43) per share Price / Book-0.30Miscellaneous Outstanding Shares6,360,000Free Float3,089,000Market Cap$4.58 million OptionableNot Optionable Beta0.66 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesDr. Hemanth Jacob Varghese CFA (Age 48)Ph.D., President & COO Comp: $582.67kMr. Ross J. Portaro (Age 60)Executive VP and GM of Global Sales & Marketing Comp: $584.62kMr. Rajiv Kanishka Liyanaarchchie De Silva (Age 57)CEO & Director Comp: $615.41kMr. Domenic Della Penna (Age 62)Executive VP & CFO Comp: $396.8kMr. Michael Mandarello (Age 38)General Counsel & Corporate Secretary Mr. William H. McGrail (Age 63)Executive Vice President of Technical Operations & Compliance Ms. Anat Kotler (Age 40)Head of Marketing & Product Management Ms. Anna Georgiadis (Age 53)Chief Human Resources Officer Dr. Yoni Iger (Age 64)Head of Scientific & Clinical Affairs Ms. Joyce MorrisHead of Sales - CanadaMore ExecutivesKey CompetitorsAcutus MedicalNASDAQ:AFIBSharps TechnologyNASDAQ:STSSAssureNASDAQ:IONMTitan MedicalNASDAQ:TMDIFAvingerNASDAQ:AVGRView All Competitors VERO Stock Analysis - Frequently Asked Questions Should I buy or sell Venus Concept stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Venus Concept in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" VERO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in VERO, but not buy additional shares or sell existing shares. View VERO analyst ratings or view top-rated stocks. How have VERO shares performed in 2024? Venus Concept's stock was trading at $1.18 at the beginning of the year. Since then, VERO stock has decreased by 38.9% and is now trading at $0.7209. View the best growth stocks for 2024 here. Are investors shorting Venus Concept? Venus Concept saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 27,700 shares, an increase of 114.7% from the March 15th total of 12,900 shares. Based on an average daily volume of 538,100 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.7% of the company's stock are short sold. View Venus Concept's Short Interest. When is Venus Concept's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 15th 2024. View our VERO earnings forecast. How can I listen to Venus Concept's earnings call? Venus Concept will be holding an earnings conference call on Wednesday, May 15th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 201-612-7415 with passcode "13745887". How were Venus Concept's earnings last quarter? Venus Concept Inc. (NASDAQ:VERO) released its earnings results on Monday, April, 1st. The company reported ($2.01) earnings per share (EPS) for the quarter. The firm earned $18.13 million during the quarter. When did Venus Concept's stock split? Venus Concept shares reverse split before market open on Friday, May 12th 2023. The 1-15 reverse split was announced on Friday, May 12th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 12th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. What guidance has Venus Concept issued on next quarter's earnings? Venus Concept updated its first quarter 2024 earnings guidance on Monday, April, 1st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $16.5 million-, compared to the consensus revenue estimate of $19.4 million. What other stocks do shareholders of Venus Concept own? Based on aggregate information from My MarketBeat watchlists, some companies that other Venus Concept investors own include Spectrum Pharmaceuticals (SPPI), CONSOL Energy (CEIX), Salesforce (CRM), Cisco Systems (CSCO), SCYNEXIS (SCYX), AzurRx BioPharma (AZRX), Boeing (BA), Interpace Biosciences (IDXG), Johnson & Johnson (JNJ) and Advanced Micro Devices (AMD). How do I buy shares of Venus Concept? Shares of VERO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:VERO) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceFed launches fourth dollar overhaulStansberry ResearchGreat Crypto BullWeiss RatingsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Venus Concept Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
